Artificial intelligence is no longer experimental in healthcare revenue cycle management, according to a recently released industry report, but fragmented data and disconnected solutions now pose the biggest threat to scaling results. AI is already reducing denials, accelerating scheduling, and lowering administrative costs, yet most organizations remain stuck in early or mid-stage maturity, limiting enterprise-wide impact.
The report paints a picture that will feel familiar to companies supporting RCM operations. While nearly two-thirds of organizations are using AI in at least one workflow, only 8% say they have reached true enterprise-scale adoption. The difference, according to the findings, is not the sophistication of AI models, but the underlying architecture supporting them.
Key findings:
- Measurable financial ROI is now real. Organizations report 20%-to-25% fewer denials through AI-enabled revenue cycle workflows, faster scheduling, and lower call center volume.
- Administrative automation is where AI is delivering value first. Adoption is concentrated in workflow automation, documentation support, patient access, and revenue cycle functions.
- Fragmented data is the top barrier to scale. Sixty-two percent of leaders cite disconnected systems and data silos as the primary obstacle to expanding AI across the enterprise.
For organizations collecting patient balances or managing downstream self-pay engagement, the implications are significant. The report notes that AI-driven denial prevention, prior authorization automation, and propensity-to-pay modeling can materially tighten days in accounts receivable, but only when built on unified data and governance. Without that foundation, AI risks becoming what the report describes as “AI sprawl,” creating more vendors, inconsistent outcomes, and compliance risk rather than operational relief.
Looking ahead, the report frames 2026 as a decisive year. Leaders are shifting investment toward unified data platforms, embedded AI copilots inside EHR and CRM systems, and stronger governance, signaling a move away from isolated pilots toward platform-based AI strategies. For RCM leaders, collection partners, and financial institutions supporting healthcare, the message is clear: AI advantage will increasingly depend on architecture, not experimentation.
